Article: Beike Biotechnology Invests in Leading Japanese Regenerative Medicine Co., Biomaster Inc.

Shenzhen Beike Biotechnology Co. Ltd. ( http://www.beikebiotech.com/ ), China's leading stem cell research and regenerative medicine company, announced that it has entered into an agreement with Yokohama-based Biomaster Inc. ( http://www.biomaster.jp/ ) for investment in its advanced technologies. Biomaster specializes in research and commercialization of adipose-based stem cell therapies. Beike, along with two investment companies, has taken a significant share in Biomaster, secured a seat on the board, and is involved in the company's strategic positioning in preparation for an eventual IPO (see also Regenerative Medicine).

Since its inception in 2002, ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!